Public Release: 

Penn team finds protein 'cement' that stabilizes the crossroad of chromosomes

Knowing the molecule that provides genome stability for cell division informs basic biology of many gene-based disorders

University of Pennsylvania School of Medicine


IMAGE: The direct binding of CENP-C to the CENP-A nucleosome stabilizes hydrogen bonding within internal secondary structures of the CENP-A nucleosome. Stars indicate fluorescent probes that move closer to each other... view more

Credit: Lucie Guo and Ben Black, Perelman School of Medicine, University of Pennsylvania

PHILADELPHIA - Cell division is the basis of life and requires that each daughter cell receive the proper complement of chromosomes. In most organisms, this process is mediated at the familiar constricted intersection of X-shaped chromosomes. This area, called the centromere, is where special proteins gather and attach to pull daughter cells apart during cell division. The structure and biology of the centromere is of considerable scientific interest because problems with it can lead to abnormalities in the chromosomes of daughter cells, which are the basis of such disorders as Down syndrome.

A new study by researchers at the Perelman School of Medicine at the University of Pennsylvania published in Science this week describes how the centromere is stabilized during replication. DNA in the nucleus is packaged into protein/DNA complexes called nucleosomes. As it turns out, the centromere is distinguished not only by its DNA sequence but also by a special type of nucleosome, which includes a protein called CENP-A.

Senior author Ben E. Black PhD, associate professor of Biochemistry and Biophysics, and his Penn team described the structure of CENP-A almost five years ago. The question the investigators asked now was, how does the cell ensure that CENP-A-containing nucleosomes remain at, and thus continue to mark, the centromere during the massive changes a cell undergoes when it divides?

Simply put, it involves an accessory protein called CENP-C. "Overall, my lab is interested in better understanding the molecular basis of inheritance and the role of the centromere, as a 'control locus,' for maintaining heredity," says Black.

His team applied a battery of biophysical techniques to study the structure and stability of CENP-A-containing nucleosomes in a test tube. Their data indicate that CENP-A-bearing nucleosomes have an unexpectedly flexible structure, adopting a relaxed conformation in the absence of CENP-C, and a more compact shape in its presence. This CENP-C-induced shape shift correlates with changes in how DNA wraps around the centromere's nucleosomes, making the structure similar to that found in living cells.

Their findings also address the question of the stability of CENP-A molecules at centromeres. Under normal conditions CENP-A binds centromeres and effectively never lets go. Indeed, when the authors tracked where proteins "reside" in live cells, they found that, unlike traditional nucleosomes that package the DNA throughout the rest of the chromosome, CENP-A-containing nucleosomes apparently never dissociate after newly generated CENP-A protein is first delivered to the centromere during a short time window following cell division. "The CENP-A is basically cemented at the centromere of origin," Black explains. But in cells lacking CENP-C, CENP-A dissociates readily, suggesting that CENP-C binding to CENP-A is what imparts that stability.

Investigators have known for the past 20 years that part of chromosome inheritance is controlled by epigenetics, implicating the protein spools around which DNA is wound as the driving force, rather than what is encoded in the DNA sequence itself. Those spools are built of histone proteins, and chemical changes to these spool proteins can either loosen or tighten their interaction with DNA. This, in turn, alters a gene's expression up or down. In the case of the centromere, it marks the site where spindle fibers attach independently of the underlying DNA sequence.

Earlier, Black and other chromosome researchers established that CENP-A is the key epigenetic protein at the centromere and replaces the regular histone protein H3. CENP-A attracts other proteins, and in cell division builds a massive structure called the kinetochore, for pulling duplicated chromosomes apart during cell division.

Black notes that these data suggest a model of epigenetic biology distinct from the traditional view of nucleosomes as static scaffolds on which key functional molecules assemble. Instead, the team's data suggest that histone variants and post-translational modifications, which change the biological properties of nucleosomes through changes in shape (by adding or removing enzyme docking sites) make nucleosomes active participants in cell division and gene expression.

"This is conceptually very similar to thinking about how enzymes can be regulated -- their activity can be turned on and off," he explains. "In this case, we're not talking about how enzymes affect a chemical reaction; we're talking about how the nucleosome and this entire part of the chromosome is stabilized. If stability is lost, then the chromosome and all the genes carried on it would not be delivered faithfully to each cell upon division. This is the sort of genetic catastrophe that is a hallmark of cancer cells. Or if it happens in the sperm or egg cell lines, it leads to spontaneous abortions or children with disorders such as Down syndrome."

This mode of nucleosome regulation and stabilization may well be common to other epigenetic processes, Black adds. Indeed, he says the results suggest that other histone variants and histone post-translational modifications may serve a similar function as the example at the centromere with CENP-A and CENP-C, for instance in the regulation of gene expression.

"I don't know how widely this occurs," he says, "but I'd be very surprised if this was the only place in nature that had evolved to take advantage of the fact that the shape of nucleosomes can be regulated by protein-binding events."

Black says CENP-A-mediated stability could explain how oocytes retain the epigenetic information that preserves the fidelity of chromosome inheritance over so many years of fertility, and he is preparing to test that hypothesis now.


Other authors include co-first authors Samantha J. Falk, Lucie Y. Guo, Nikolina Sekulic, and Evan M. Smoak, along with Tomoyasu Mani, Glennis A. Logsdon, Kushol Gupta, Gregory D. Van Duyne, Sergei A. Vinogradov, and Michael A. Lampson, all from Penn, and Lars E. T. Jansen of the Instituto Gulbenkian de Ciência, Oeiras, Portugal.

The study was supported in part by the National Institute of General Medical Sciences (GM082989), the National Cancer Institute (CA186430), the National Science Foundation (DMR-0944772), the National Institute of Standards and Technology, the American Heart Association, the American Cancer Society, and the European Research Council.

Penn Medicine is one of the world's leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $4.9 billion enterprise.

The Perelman School of Medicine has been ranked among the top five medical schools in the United States for the past 17 years, according to U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $409 million awarded in the 2014 fiscal year.

The University of Pennsylvania Health System's patient care facilities include: The Hospital of the University of Pennsylvania -- recognized as one of the nation's top "Honor Roll" hospitals by U.S. News & World Report; Penn Presbyterian Medical Center; Chester County Hospital; Penn Wissahickon Hospice; and Pennsylvania Hospital -- the nation's first hospital, founded in 1751. Additional affiliated inpatient care facilities and services throughout the Philadelphia region include Chestnut Hill Hospital and Good Shepherd Penn Partners, a partnership between Good Shepherd Rehabilitation Network and Penn Medicine.

Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2014, Penn Medicine provided $771 million to benefit our community.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.